Wilmer Cutler Pickering Hale and Dorr advised Eliem Therapeutics on the deal, and Cooley advised Tenet Medicines. Eliem Therapeutics, Inc. (Nasdaq: ELYM), announced that it had entered into...
You must be a Standard 1 Year member to access this content.
Cooley and JunHe advised ImmuneOnco Biopharmaceuticals on the offering, and Kirkland & Ellis and Jingtian & Gongcheng advised the joint sponsors and underwriters. ImmuneOnco Biopharmaceuticals announced...
You must be a Standard 1 Year member to access this content.
Cooley represented Zoetis, while Davis Polk advised the joint book-running managers in the offering. Zoetis Inc. executed its offering of $600 million aggregate principal amount of its...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Huitongda Network Co., Ltd. on the deal while Cooley advised the joint sponsors and underwriters. Founded in late 2010, Nanjing-based Huitongda is...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised BowX Acquisition Corp. on the deal while Morrison & Foerster LLP represented SoftBank Group Corp. Willkie Farr & Gallagher LLP advised Insight Partners...
You must be a Standard 1 Year member to access this content.
